We are live on ! Find out more
AIM icon

AIM ImmunoTech

32 hedge funds and large institutions have $5.92M invested in AIM ImmunoTech in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 1

650% more capital inflows, than outflows

Capital inflows: $2.54M | Capital outflows: $338K

200% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 5

45% more funds holding

Funds holding: 22 → 32 (+10)

1.19% more ownership

Funds ownership: 5.74% → 6.93% (+1.2%)

Holders
32
Holders Change
+10
Holders Change %
+45.45%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
10
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

AIM Hedge Fund Activity: Q3 2020 in Review

32 of the 4,973 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q3 2020, worth a combined $5.92M — up 27% from $4.64M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AIM positions and 5 closed out — a net gain of 10 holders — while 10 added to existing stakes and 1 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $823K. The largest seller was Virtu Financial, cutting an estimated $92.4K.

  • 32 institutional investors held AIM ImmunoTech (AIM) as of Q3 2020, up from 22 in Q2 2020.
  • Funds reported $5.92M of AIM ImmunoTech stock for Q3 2020, up 27% quarter-over-quarter.
  • 15 funds opened new AIM ImmunoTech positions in Q3 2020 and 5 closed out, a net change of +10 holders.
  • The largest AIM ImmunoTech buyer in Q3 2020 was Morgan Stanley, an estimated $823K added.
  • The largest AIM ImmunoTech seller in Q3 2020 was Virtu Financial, an estimated $92.4K sold.

Based on aggregated 13F filings for Q3 2020.